Jazz Pharmaceuticals (JAZZ) Return on Invested Capital (2012 - 2026)

Jazz Pharmaceuticals' Return on Invested Capital history runs 15 years deep, the most recent figure standing at 0.0% for Q1 2026.

• On a quarterly basis, Return on Invested Capital fell 1.0% year-over-year to 0.0% in Q1 2026; TTM through Mar 2026 was 0.0%, a 1.0% decrease from a year earlier, with the FY2025 full-year figure at 0.0%, down 3.0% from the prior year.
• Return on Invested Capital grew to 0.0% in Q1 2026 per JAZZ's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.01% in Q4 2023 and bottomed at 0.0% in Q3 2023.
• The 5-year median for Return on Invested Capital is 0.0% (2022), against an average of 0.0%.
• Biggest YoY gain for Return on Invested Capital was 1 bps in 2022; the steepest drop was 1 bps in 2022.
• Year by year, Return on Invested Capital stood at 0.0% in 2022, then jumped by 371 bps to 0.01% in 2023, then slumped by 33 bps to 0.01% in 2024, then tumbled by 117 bps to 0.0% in 2025, then jumped by 102 bps to 0.0% in 2026.
• Per Business Quant, the three latest JAZZ Return on Invested Capital figures stand at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).